NEW YORK – Researchers used patient-derived organoids to test the activity of different drugs, and based on the results, changed treatments for two metastatic colorectal cancer patients, according to a recently published study.
NEW YORK – Researchers used patient-derived organoids to test the activity of different drugs, and based on the results, changed treatments for two metastatic colorectal cancer patients, according to a recently published study.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.